Will the medication be covered
European health care systems, with universal coverage and prioritization on preventive care, have been rather open to the use of GLP-1, especially in patients with cardiovascular disease or who are at high risk of cardiovascular disease, with health technology assessment (HTA) of good cost-effectiveness
View BPC-157
When it comes to effectiveness, potency and purity, their products are superior
The timeline for visible results depends on several factors, including your starting point, age, overall health, and consistency with supplementation
Individual response depends on hormones, amino acids, and overall health